Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9637459
APP PUB NO 20150038514A1
SERIAL NO

14381618

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to sodium and calcium salts of {8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazoline-4-yl}acetic acid and solvates thereof, to the use thereof in a method of treatment and/or prophylaxis of virus infections and to the use thereof for producing drugs for use in methods of treatment and/or prophylaxis of diseases, more particularly the use thereof as antiviral agents, more particularly against cytomegaloviruses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AIC246 AG & CO KGFRIEDRICH-EBERT-STRASSE 475 WUPPERTAL 42117

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aret, Edwin CJ Almere, NL 18 64
Berwe, Mathias Sprockhovel, DE 11 108
Grunenberg, Alfons Wuppertal, DE 36 231
Keil, Birgit Dusseldorf, DE 31 108
Paulus, Kerstin Ratingen, DE 11 71
Schwab, Wilfried Velbert, DE 60 614

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00